Objective: To determine if the second trimester placental location is associated with perinatal outcomes.
Introduction
A detailed ultrasound for fetal anatomy is now routinely performed on the majority of pregnant women in the United States and in many industrialized nations. Besides the evaluation of fetal anatomy, an assessment of the uterus placental implantation site and its relationship to the internal cervical os is noted.
Complete placenta previas and marginal previas are serially monitored for migration over the course of the pregnancy, and if that location persists, are delivered abdominally. If the leading edge of the placenta remains within 2 cm of the internal os over the course of the pregnancy, this frequently leads to an abdominal delivery because of the unacceptably high risk of hemorrhage with a vaginal delivery. 1 Pregnancies complicated by placenta previa are reported to have a reduced risk of hypertensive disorders of pregnancy compared with normally implanted placentas 2 and low lying placentas (placentas in the lower uterine segment but which are not placenta previas) are associated with an increased risk of postpartum hemorrhage. 3 Other placental implantation sites have been associated with adverse maternal and neonatal outcome in small investigations. Unilateral placental implantations (placentas where the bulk of the placenta is implanted over the right or left lateral aspect of the uterus) have been linked with an increased incidence of preeclampsia, fetal distress in labor, abdominal deliveries and intrauterine growth retardation (IUGR). 4, 5 Cornual implantations have been linked with an increased risk of breech presentations, 6 persistent placenta previas with fetal growth restriction, abruption placenta and third trimester bleeding. 7 Despite the universal documentation of placental location at the time of the second trimester ultrasound evaluation of the fetal anatomy, a detailed appraisal of that location, with the exception of placenta previas, and its predictability of adverse perinatal and maternal outcomes in a large prospective study has not been undertaken. The purpose of this investigation was to find out if the initial site of placental implantation, as determined by ultrasound between 14 and 22 weeks of gestation, is predictive of antepartum complications, intrapartum events and neonatal outcomes.
Materials and methods
These observational cohort studies investigated women from Mississippi and pregnancies from the Western Australian pregnancy cohort that assessed the effects of a single vs multiple ultrasounds on antepartum, intrapartum, postpartum and neonatal outcomes, 8 and that study had been approved by the Ethics Committee at King Edward Memorial Hospital, Subiaco, Western Australia. The patients were recruited from consecutive women presenting to the ultrasound units for a fetal anatomic survey in the second trimester of pregnancy and are representative of the women managed at each respective medical center. All of the recruited women are included in the analysis. The patients from the Western Australian pregnancy cohort have been published previously in an investigation evaluating placental migration in pregnancy. 9 The Mississippi women part of this investigation was approved as an exempt study by the Institutional Review Board (IRB) as a prospective observational investigation of placental location and correlated with antepartum, intrapartum postpartum and neonatal outcomes. The same methods of assessment of placental location and obstetrical outcomes were implemented in both studies. The Mississippi data set and the larger data set from Western Australia were individually evaluated and as there was no outcome differences based on placental implantation in the second trimester observed between the two data sets, the sets were combined.
Outcomes considered included placenta previa, placental abruption, any bleeding during pregnancy, preterm labor (uterine contractions with cervical change), abnormal presentation, fetal growth restriction (<10%), preeclampsia, preterm delivery (delivery before 37 weeks of gestation), 1-min and 5-min Apgar scores (<7) and postpartum hemorrhage (blood loss in excess of 1000 ml, drop in the hematocrit of 10 points or need for blood transfusion because of hemodynamic instability). Macrosomia is defined as >90% by weight for gestational age. Analysis was performed using the cases from Mississippi combined with the Australian data set. Ten distinct placental implantation sites were identified based on our previous investigation assessing placental migration. 9 All of the sonographers were asked to label the placental implantation site as that site where the bulk of the placenta was located and this was based on the figures available to all of them from our previous investigation (Figure 1 ). The groupings of the placentas were done on a location and functional basis with anterior and posterior locations in the same area (fundus vs lower uterine segment) of the uterus grouped together and lateral implantations grouped together based on their close proximity to the uterine and ovarian blood supplies. The low placenta groups (0, 8, 9) were all either partial previas or the leading edge of the placenta was within 2 cm of the internal cervical os, but none stayed either partial previas or remained within 2 cm of the internal os at delivery. None of the placenta previas or partial previas that remained at delivery were included in the analyses. All placenta previas, partial previas and low implantation sites were analyzed with both abdominal and vaginal ultrasounds and reanalyzed in the third trimester of pregnancy to determine if the initial implantation site had migrated. In all analyses, the 10 placental locations were initially categorized into four groups (low 1: low central (0), right low (8) and left low (9); low 2: low 6 and post low 7; high lateral: left high 2 and right high 3; and high fundal: fundal (1), ant high 4, post high 5, where the high 2 was the reference group selected as the most common). For analysis purposes, groups low 1 and low 2 were combined into one category because of very low rate of the group low 1 encountered (only two cases in the Mississippi data set and 16 cases in the Western Australia dataset), resulting in a low group, high lateral and high fundal.
Descriptive statistics utilized means and standard deviations (s.d.) or medians and interquartile ranges (1st quartile to 3rd quartile, shown as Q 1 to Q 3 ) or ranges (minimum to maximum) and percentages, as appropriate for continuous or categorical data. Multivariable logistic regression was used to investigate factors associated with each pregnancy outcome considered. For all comparisons the most common placental location -fundal, posterior and anterior high -was selected as the reference category, and the high lateral and low implantations were compared to that group. Effects of placental location on pregnancy outcomes were summarized using odds ratios (ORs) and their 95% confidence intervals (CIs). Univariate and adjusted ORs were obtained to account for potential confounding, and the set of adjustment covariates is listed in the analysis of each pregnancy outcome. 'Cohort effect' was always considered as one of the confounders to account for a possibility of unspecified management variations between Western Australia and Mississippi that may effect the pregnancy outcomes. Statistical analysis was conducted using SPSS statistical software (SPSS Version 11.0, Inc., Chicago, IL, USA). All statistical tests were two-sided and P-values <0.05 were considered statistically significant.
Results
From Mississippi, 598 women were recruited between 2000 and 2003, and 2900 women were recruited form the Western Australian pregnancy cohort between 1989 and 1992 (with 2752 singleton pregnancies in which placental location recorded). Overall, 3336 pregnancies with ascertained placental location and pregnancy outcomes were available for the analysis of pregnancy outcomes. The maternal demographic characteristics, risk factors affecting placental implantation, medical complications and complications of pregnancy are shown for the combined data sets as Table 1 .
Seven cases of placenta previa (0.02%) were observed, and those were excluded from the analysis.
Antepartum and delivery outcomes stratified by placental location are shown complications in Table 2 . Delivery and postpartum outcomes are in Table 3 . In pregnancies with low implantations (Low), there is a greater risk of preterm labor (OR 1.70, 95% CI 1.38 to 2.90, P<0.001), preterm delivery (OR 1.86, 95% CI 1.36 to 2.54, P<0.001) and fewer fetuses with macrosomia (OR 0.56, 95% CI 0.38 to 0.83, P ¼ 0.010) and reduced risk of postpartum hemorrhage (OR 0.56, 95% CI 0.46 to 0.95, P ¼ 0.026). There was a greater risk of having low 1 and 5 min Apgar scores with high 1 (left and right high) implantations (OR 1.80, 95% CI 1.11 to 2.93, P ¼ 0.017) and (OR 3.49, 95% CI 1.46 to 8.36, P ¼ 0.005) and for the combined Mississippi and Australian data set in Table 3 .
Discussion
In the United States, screening ultrasounds of a large proportion of pregnant women are undertaken and they generally receive at least one obstetric ultrasound for gestational age, amniotic fluid volume, fetal anatomic survey and placental location. With the exception of the identification of a low-lying or a placenta previa, the other implantation sites are noted and then no further attention is paid to those sites. Are these implantation sites predictive of an adverse pregnancy outcome? Only a limited number of investigations have dealt with the placental implantation site and pregnancy outcomes. [2] [3] [4] [5] [6] [7] In this investigation, in pregnancies with a low placental implantation, there was an increased risk of preterm labor and preterm delivery at 14 to 22 weeks. This association was present Other include: NRST/low BP, HIV, oligohydramnios, polyhydramnios, seizure disorder, PTL, congenital abnormalities.
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following a univariate analysis and persisted with the adjusted OR. The reason for this increased risk of preterm delivery beyond that which would be observed secondary to placenta previas, partial previas and placentas that remained within 2 cm of the internal os (not included in the analysis) remains uncertain, and all deliveries in these cases were abdominal at fetal lung maturity. The absence of growth restriction in these pregnancies suggests that overall blood flow and a hostile uterine environment is not the etiology of the preterm deliveries. The risk of developing preeclampsia was not increased in this investigation by the site of placental implantation. Other investigators have reported a reduced risk with low implantation 2 and increased risk with unilateral implantation. 4 The investigation by Gonser et al. 4 studies prospectively only 184 pregnant women in the association of lateral implantation with the 3400 in our study and the increased risk of preeclampsia, whereas the Leiberman study 2 compared 491 women with placenta previa among a population of 106 866 women with normally implanted placentas. Our study with a total of only 344 women with low implantations may have had too few women to demonstrate a difference in developing preeclampsia.
Additionally in the assessment of laterally implanted placenta, Vaillant et al. 5 discovered an increased risk of fetal distress in labor, cesarean deliveries and IUGR. The Valliant study 5 compared 75 women with laterally implanted placentas with 21 women with centrally implanted placentas. We also observed that high lateral implantations have a significantly greater number of neonates with Apgar scores <7 at both 1 and 5 min. The reason for this is unclear.
An abnormal presentation was not influenced by placental implantation site in our study. Fianu and Vaclavinkova 6 did find more breech with cornual implantation (fundal lateral) with a number of women with lateral implantations similar to ours; although in that study the placental implantation site associated with breech was a cornual implantation.
The risk of having a fetus with IUGR was not increased in our study by the site of placental implantation. An increased risk of IUGR has been reported for both high lateral implantations 5 and low implantations. 7 Interestingly in our study, not only were the high lateral implantations not linked with IUGR but also the low implantations had a significantly reduced risk of macrosomia suggesting larger babies for all of the high placental locations. At least in theory, a placenta which is primarily implanted near the uterine and/or ovarian arteries might receive more blood flow than the one implanted centrally either anterior or posterior, and this 263 (8) 234 (8) 22 (7) 7 (8) 0.678 <5%
106 (3) 91 (3) 12 (4) 3 (3) Macrosomia (>90%) 308 (9) 279 (10) 18 (6) could account for the larger neonates with unilaterally implanted placentas in this study.
The possibility of a postpartum hemorrhage was reduced in our study with placentas that were implanted low. All of the low-lying placentas that were within 2 cm of the internal os, were delivered by cesarean section at fetal lung maturity. In those remaining placentas that were >2 cm from the internal os, there was no increased risk of postpartum hemorrhage. There were no placenta accretas in the group of women with a low implantation of their placentas.
There are several limitations of this investigation. One of the limitations is that with the initial 10 implantation sites, many of the sites had too few pregnancies to analyze and correlate that site with pregnancy outcomes. This necessitated combining the 10 sites into three sites. The grouping of the placentas was carried out on a location and functional basis with anterior and posterior locations in the same area (fundus vs lower uterine segment) of the uterus grouped together and lateral implantations grouped together based on their close proximity to the uterine and ovarian blood supplies. We believe that this three-group categorization is more realistic reflect of how the clinical will classify the site, and all the sites within each group have similar vascularization. The second limitation is the combination of two data sets. The methods of assessment of placental location and obstetrical outcomes were similar in the two studies. Additionally, the Mississippi data set and the larger data set from Western Australia were individually evaluated and then as there was no outcome differences based on placental implantation in the second trimester observed between the two data sets, the sets were combined, and we believe this procedure valid and enables us to evaluate larger single data set.
Placental implantation at 14 to 22 weeks can be used in the evaluation of pregnancies to categorize them as being at risk for an adverse antepartum, intrapartum and neonatal outcome. Preterm labor and preterm deliveries occur more frequently, and postpartum hemorrhage and macrosomic fetuses occur less frequently in low placental implantation sites. High lateral placental implantations are associated with lower Apgar scores. Future investigations will need to confirm the findings of this investigation. If these observations remain valid in future investigations, then the placental implantation site on the second trimester targeted ultrasound can be used to label a pregnancy as 'at risk' and follow-up ultrasounds or other surveillance techniques might be used to ensure the best pregnancy outcome. Abbreviations: CI, confidence interval; OR, odds ratio. Univariate analyses only were performed, also with the exclusion of location high lateral due to very sample size limitations. Adjusted OR: Any abortions -cohort effect and maternal age; any bleeding in pregnancy -cohort effect; abnormal presentation -cohort effect, nulliparity, maternal age, gestational age at delivery; threatened preterm labor -cohort effect, nulliparity, maternal age and alcohol consumed during pregnancy; preterm delivery -cohort effect, alcohol in pregnancy, preexisting medical conditions; IUGR -cohort effect, nulliparity, smoking during pregnancy, pre-existing diabetes and gestational age at delivery; Macrosomia -cohort effect, smoking during pregnancy and pre-existing diabetes and gestational age at delivery; Apgar <7 at 1 min -cohort effect, nulliparity, macrosomia and gestational age at delivery; Apgar <7 at 5 min -cohort effect, and nulliparity; PPH -cohort effect, and pre-existing diabetes.
